title: A rational design approach for developing immunomodulators based on CD4 and CD8.
authors.affiliation: Department of Biochemistry, School of Medicine, MCP Hahnemann University, 245 North 15th Street, Philadelphia, PA 19102, USA.
authors.forename: Anna P
authors.initials: AP
authors.lastname: Tretiakova
authors.forename: Ross H
authors.initials: RH
authors.lastname: Albert
authors.forename: Bradford A
authors.initials: BA
authors.lastname: Jameson
mesh_terms: D000276:Adjuvants, Immunologic / Q000138:chemical synthesis* / Q000627:therapeutic use; D000818:Animals; D015703:Antigens, CD / Q000276:immunology; D015704:CD4 Antigens / Q000276:immunology*; D016827:CD8 Antigens / Q000276:immunology*; D015195:Drug Design; D006801:Humans; D051379:Mice; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D015703:Antigens, CD; D015704:CD4 Antigens; D016827:CD8 Antigens